Charles River Laboratories | CRL - Pe Kurs-Gewinn

Aktienkurs
153.46
Täglich Wechseln
2.61 1.73%
Monatlich
-17.29%
Jährlich
8.54%
Q2 Prognose
147.82




Pe Veränderung Datum
Agilent 25.04 2.13 2025-12
Align Technology 22.78 3.05 2026-03
Bio-Rad Laboratories 25.28 8.86 2025-12
Bruker 36.79 44.56 2026-03
Cardinal Health 30.4 5.87 2026-03
Charles River Laboratories 29.26 14.31 2026-03
Cigna 10.56 0.76 2025-12
CVS Health 9.65 4.74 2026-03
Danaher 29.29 10.39 2026-03
Dentsply International 20.31 9.68 2026-03
Elevance Health 12.4 0.98 2026-03
Humana 11.07 14.98 2026-03
Illumina 32.45 2.07 2026-03
Incyte 15.35 0.51 2026-03
Intrexon 7.54 221.44 2021-12
IQVIA Holdings 19.37 7.21 2026-03
Laboratory Of America 25.51 4.65 2026-03
Lakefront Biotherapeutics 2.54 0.6 2026-03
Lonza 34.34 2.58 2025-12
McKesson 23.85 0.07 2025-12
Merck 12.74 7.82 2026-03
Mettler Toledo International 27.34 5.07 2026-03
Novartis 20.17 2.32 2026-03
Pfizer 9.32 5.16 2026-03
Quest Diagnostics 22.4 2.63 2026-03
Revvity 30.79 19.08 2026-03
Thermo Fisher Scientific 27.71 3.29 2026-03
United Therapeutics 20.42 3.1 2026-03
UnitedHealth 15.29 4.5 2026-03
Veradigm 11.15 4.63 2022-09
Waters 29.75 5.54 2026-03
West Pharmaceutical Services 31.99 5.76 2026-03